ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )
🇨🇳China
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Not Applicable
Recruiting
- Conditions
- Meningioma
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06955208
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang,, Liaoning, China
MR Elastography in Intracranial Lesions: Feasibility & Accuracy
Active, not recruiting
- Conditions
- Brain Neoplasms
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 512
- Registration Number
- NCT06916715
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang,, Liaoning, China
Evaluation of the Efficacy of the Two-point Method in Percutaneous Transhepatic Choledoscopy and the Influence of the Long-term Recurrence of Hepatolithiasis
Not Applicable
Completed
- Conditions
- HepatolithiasisEndoscopy, Digestive System
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 157
- Registration Number
- NCT06839612
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
Recruiting
- Conditions
- Chronic Hepatitis BLiver Fibrosis
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06779058
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06698679
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 840
- Registration Number
- NCT06690645
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
A Clinical Study of Hyperthyroidism in Children
Recruiting
- Conditions
- Hyperthyroidism
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06570967
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection
Phase 1
Completed
- Conditions
- Acute Upper Respiratory Tract InfectionRandomised Controlled TrialTraditional Chinese Medicine
- Interventions
- Drug: Qing Re He Ji
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 268
- Registration Number
- NCT06520618
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess
Recruiting
- Conditions
- Liver Abscess
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 550
- Registration Number
- NCT06506318
- Locations
- 🇨🇳
Shengjing hospital of China medical university, Shenyang, Liaoning, China
Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)
Not yet recruiting
- Conditions
- Liver AbscessTACEHCC - Hepatocellular Carcinoma
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06483594
© Copyright 2025. All Rights Reserved by MedPath